Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial

Vaccine

Volumn 29, Issue 44, 2011, Pages 7595-7598

  van Gils, Elske J M ^a,b   Veenhoven, Reinier H ^b   Rodenburg, Gerwin D ^a   Hak, Eelko ^c   Sanders, Elisabeth A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Carriage; Colonization; Haemophilus influenzae; Infants; Moraxella catarrhalis; Otitis media; Pneumococcal conjugate vaccine; Replacement

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; CHILD; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MALE; MORAXELLA CATARRHALIS; NASOPHARYNX; NOSE SMEAR; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THROAT CULTURE;

CARRIER STATE; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MORAXELLA (BRANHAMELLA) CATARRHALIS; NASOPHARYNX; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 80053607675     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.049     Document Type: Article

References (20)

1. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000, 19(March (3)):187-195.
2. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001, 344(February (6)):403-409.
3. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007, 196(October (8)):1211-1220.
4. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999, 180(October (4)):1171-1176.
5. Obaro S.K., Enwere G.C., Deloria M., Jaffar S., Goldblatt D., Brainsby K., et al. Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 2002, 21(October (10)):940-947.
6. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003, 37(November (9)):1155-1164.
7. Leibovitz E., Jacobs M.R., Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J 2004, 23(December (12)):1142-1152.
8. Murphy T.F., Parameswaran G.I. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 2009, 49(July (1)):124-131.
9. van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. JAMA 2009, 302(July (2)):159-167.
10. O'Brien K.L., Nohynek H. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003, 22(February (2)):e1-e11.
11. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988, 44(December (4)):1049-1060.
12. van O.M., de Greeff S.C., Spanjaard L., Schouls L.M. Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme. Euro Surveill 2006, 11(6):E060608.
13. van Gils E.J., Hak E., Veenhoven R.H., Rodenburg G.D., Bogaert D., Bruin J.P., et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One 2011, 6(6):e20229.
14. Block S.L., Hedrick J., Harrison C.J., Tyler R., Smith A., Findlay R., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004, 23(September (9)):829-833.
15. Casey J.R., Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004, 23(September (9)):824-828.
16. Casey J.R., Adlowitz D.G., Pichichero M.E. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010, 29(April (4)):304-309.
17. Pichichero M.E., Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007, 298(October (15)):1772-1778.
18. Dabernat H., Seguy M., Faucon G., Delmas C. Epidemiology of Haemophilus influenzae strains collected in 2004 in France and in vitro assessment of their susceptibility to antibiotics. Med Mal Infect 2007, 37(June (6)):320-324.
19. Garcia-Cobos S., Campos J., Lazaro E., Roman F., Cercenado E., Garcia-Rey C., et al. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 2007, 51(July (7)):2564-2573.
20. Lysenko E.S., Lijek R.S., Brown S.P., Weiser J.N. Within-host competition drives selection for the capsule virulence determinant of Streptococcus pneumoniae. Curr Biol 2010, 20(July (13)):1222-1226.